Filing Details
- Accession Number:
- 0001104659-23-001900
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-06 17:00:48
- Reporting Period:
- 2023-01-04
- Accepted Time:
- 2023-01-06 17:00:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1407451 | N Laurence Charney | 2 Gansevoort Street, 9Th Floor New York NY 10014 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-01-04 | 30,000 | $11.10 | 234,729 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- In connection with the vesting of 100,878 shares on January 1, 2023, 30,000 shares were sold in order to cover the reporting person's income tax obligations.
- Reflects the weighted average sale price. The range of prices for the shares sold was $10.91 to $11.38. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes shares of restricted Common Stock, which vest over various time periods.